Cargando…

SLC39A4 as a Novel Prognosis Marker Promotes Tumor Progression in Esophageal Squamous Cell Carcinoma

BACKGROUND: Solute carrier family 39 member 4 (SLC39A4) has been reported to play an oncogenic role in several cancers. However, the role of SLC39A4 in esophageal squamous cell carcinoma (ESCC) remains unclear. In this study, we aimed to explore the clinical significance and function of SLC39A4 in E...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xia, Chenmei, Chen, Xia, Li, Jun, Chen, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227820/ https://www.ncbi.nlm.nih.gov/pubmed/32494154 http://dx.doi.org/10.2147/OTT.S245094

Ejemplares similares

SLC39A6: a potential target for diagnosis and therapy of esophageal carcinoma
por: Cui, Xiao-Bin, et al.
Publicado: (2015)

CD39-Expressing CD8(+) T Cells as a New Molecular Marker for Diagnosis and Prognosis of Esophageal Squamous Cell Carcinoma
por: Liu, Meitong, et al.
Publicado: (2023)

The Deubiquitinase USP39 Promotes Esophageal Squamous Cell Carcinoma Malignancy as a Splicing Factor
por: Zhu, Xiaolin, et al.
Publicado: (2022)

Defect of SLC38A3 promotes epithelial-mesenchymal transition and predicts poor prognosis in esophageal squamous cell carcinoma
por: Liu, Rui, et al.
Publicado: (2020)

Microarray analyses reveal genes related to progression and prognosis of esophageal squamous cell carcinoma
por: Qixing, Mao, et al.
Publicado: (2017)

Knockdown of SLC39A14 inhibits glioma progression by promoting erastin-induced ferroptosis SLC39A14 knockdown inhibits glioma progression
por: Zhang, Yunwen, et al.
Publicado: (2023)

Upregulated Solute Carrier SLC39A1 Promotes Gastric Cancer Proliferation and Indicates Unfavorable Prognosis
por: Yu, Dan, et al.
Publicado: (2022)

SLC39A1 Overexpression is Associated with Immune Infiltration in Hepatocellular Carcinoma and Promotes Its Malignant Progression
por: Ma, Xiaowu, et al.
Publicado: (2022)

CD73 Promotes Tumor Progression in Patients with Esophageal Squamous Cell Carcinoma
por: Chen, Yen-Hao, et al.
Publicado: (2021)

USP9X expression correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma
por: Peng, Jing, et al.
Publicado: (2013)

SLC39A8/Zinc Suppresses the Progression of Clear Cell Renal Cell Carcinoma
por: Liu, Lilong, et al.
Publicado: (2021)

Analysis of the Fibrinogen and Neutrophil–Lymphocyte Ratio in Esophageal Squamous Cell Carcinoma: A Promising Blood Marker of Tumor Progression and Prognosis
por: Arigami, Takaaki, et al.
Publicado: (2015)

SLC39A10 Upregulation Predicts Poor Prognosis, Promotes Proliferation and Migration, and Correlates with Immune Infiltration in Hepatocellular Carcinoma
por: Ma, Zuyi, et al.
Publicado: (2021)

Esophageal squamous cell carcinoma and prognosis in Taiwan
por: Cheng, Ya‐Fu, et al.
Publicado: (2018)

Overexpression of GPR39 contributes to malignant development of human esophageal squamous cell carcinoma
por: Xie, Fajun, et al.
Publicado: (2011)

The DMRTA1-SOX2 positive feedback loop promotes progression and chemotherapy resistance of esophageal squamous cell carcinoma
por: ZHANG, RUI, et al.
Publicado: (2023)

The Accumulation and Prognosis Value of Tumor Infiltrating IL-17 Producing Cells in Esophageal Squamous Cell Carcinoma
por: Lv, Lin, et al.
Publicado: (2011)

High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma
por: Abudureheman, Abulajiang, et al.
Publicado: (2018)

Tumor-associated macrophage polarization promotes the progression of esophageal carcinoma
por: Yuan, Xin, et al.
Publicado: (2020)

FOXO1 promotes tumor progression by increased M2 macrophage infiltration in esophageal squamous cell carcinoma
por: Wang, Ying, et al.
Publicado: (2020)

PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma
por: Cui, Xiao-bin, et al.
Publicado: (2016)

Role of SLC39A6 in the development and progression of liver cancer
por: Wan, Zhen, et al.
Publicado: (2022)

MIR548P and TRAV39 Are Potential Indicators of Tumor Microenvironment and Novel Prognostic Biomarkers of Esophageal Squamous Cell Carcinoma
por: Xu, Jian, et al.
Publicado: (2022)

Environmental Cadmium Exposure Promotes the Development, Progression and Chemoradioresistance of Esophageal Squamous Cell Carcinoma
por: Chen, Jiongyu, et al.
Publicado: (2022)

12-lipoxygenase promotes tumor progress by TGF-β1-mediated epithelial to mesenchymal transition and predicts poor prognosis in esophageal squamous cell carcinoma
por: Qu, Yan, et al.
Publicado: (2019)

MLL3 promotes the senescence of esophageal squamous cell carcinoma
por: Xia, Manhui, et al.
Publicado: (2019)

Aberrant methylation of DACT1 and DACT2 are associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma
por: Guo, Yan-li, et al.
Publicado: (2017)

BAG2 Overexpression Correlates with Growth and Poor Prognosis of Esophageal Squamous Cell Carcinoma
por: Hong, Ying-Cai, et al.
Publicado: (2018)

DEPTOR suppresses the progression of esophageal squamous cell carcinoma and predicts poor prognosis
por: Ji, Yan-Mei, et al.
Publicado: (2016)

SLC39A1 contribute to malignant progression and have clinical prognostic impact in gliomas
por: Wang, Peng, et al.
Publicado: (2020)

Transgelin promotes ferroptosis to inhibit the malignant progression of esophageal squamous cell carcinoma
por: Chen, Qiuyu, et al.
Publicado: (2023)

The Zinc Transporter SLC39A10 Plays an Essential Role in Embryonic Hematopoiesis
por: He, Xuyan, et al.
Publicado: (2023)

IL-17A promotes migration and tumor killing capability of B cells in esophageal squamous cell carcinoma
por: Lu, Lin, et al.
Publicado: (2016)

Expression of P-EGFR and P-Akt protein in esophageal squamous cell carcinoma and its prognosis
por: Shan, Zheng-Zheng, et al.
Publicado: (2017)

Decreased SLC39A1 (Solute carrier family 39 member 1) expression predicts unfavorable prognosis in patients with early-stage hepatocellular carcinoma
por: Zhang, Qinglin, et al.
Publicado: (2021)

Serum metabolomics analysis for the progression of esophageal squamous cell carcinoma
por: Li, Xia, et al.
Publicado: (2021)

HLA complex P5 upregulation is correlated with poor prognosis and tumor progression in esophageal squamous cell carcinoma
por: Wang, Yaqin, et al.
Publicado: (2022)

Elevated p53 expression levels correlate with tumor progression and poor prognosis in patients exhibiting esophageal squamous cell carcinoma
por: HUANG, KATE, et al.
Publicado: (2014)

Signatures within esophageal microbiota with progression of esophageal squamous cell carcinoma
por: Li, Minjuan, et al.
Publicado: (2020)

Preoperative blood-routine markers and prognosis of esophageal squamous cell carcinoma: The Fujian prospective investigation of cancer (FIESTA) study
por: Hu, Dan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9qkop1jdmbon0g8u8np6q7lebq